Shmuel Yaccoby, Ph.D. Associate Professor of Medicine and Physiology
Ph.D., Department
of Animal Science, The Hebrew University of Jerusalem, Israel Post doctoral study at the Department of
Physiology-Biophysics, University of Arkansas for Medical Sciences Research Fellow, Myeloma and
Transplantation Research Center, University of Arkansas for Medical Sciences Research interest: Dr. Yaccoby seeks to elucidate the roles of various cells in the
bone marrow microenvironment, such as bone and neovascular
endothelial cells, in the pathogenesis of multiple myeloma. He is
also studying the interaction between human hematopoietic stem
cells and bone cells.
Selected Publications:
Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy, JD Jr: Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple growth in-vivo. Blood 109:2106-11, 2007.
Yaccoby S, Johnson CL, Mahaffey S, Wezeman MJ, Barlogie B, Epstein J: Anti-myeloma efficacy of thalidomide in the SCID-hu model. Blood 100: 4162-4168, 2002
Yaccoby S, Wezeman MJ, Henderson A, Fox MH, Qing Y, Barlogie B, Epstein J: Cancer and the microenvironment: Myeloma-osteoclast interactions as a model. Cancer Res. 64: 2016-2023, 2004.
Yata K, Yaccoby S: The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 18: 1891-1897, 2004.
Yaccoby S: The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, apoptosis-resistant phenotype. Clinical Cancer Research. 11: 7599-7606, 2005.
Yaccoby S, Wezeman MJ, Zangari M, Walker R, Cottler-Fox M, Gaddy D, Ling W, Saha R, Barlogie B, Tricot G, Epstein J: Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model. Haematologica. 91: 192-199, 2006.
Ge Y, Zhan F, Barlogie B, Epstein B, Shaughnessy J, Yaccoby S: Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival. Br J Haematol. 133: 83-92, 2006.
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.